---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-051179"
form_type: "8-K"
ticker: "CRNX"
cik: "0001658247"
company_name: "Crinetics Pharmaceuticals, Inc."
filed_at: "2025-04-04T23:59:59+00:00"
generated_at: "2026-05-23T21:07:35.420193+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Former CFO Marc Wilson transitions to consultant role through April 2026

## Summary
- Wilson resigned as employee on April 1, 2025, and entered a consulting agreement through April 1, 2026, with a possible six-month extension.
- He will receive $300 per hour for services plus reimbursement of reasonable out-of-pocket expenses.
- Outstanding equity awards continue vesting during consulting period; accelerates upon termination without cause, death, disability, or change in control.
- The agreement includes a general release of claims against the company.

## SEC filing metadata
- accession: 0000950170-25-051179
- form_type: 8-K
- ticker: CRNX
- cik: 0001658247
- company_name: Crinetics Pharmaceuticals, Inc.
- filed_at: 2025-04-04T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1658247/000095017025051179/0000950170-25-051179-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1658247/000095017025051179/crnx-20250401.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-051179
- JSON: https://secwatch.observer/filing/0000950170-25-051179.json
- Plain text: https://secwatch.observer/filing/0000950170-25-051179.txt

## Key facts
- Executive change
  Marc Wilson resigned as other at Crinetics Pharmaceuticals, Inc..
  - Action: resigned
  source text: pursuant to which Mr. Wilson resigned as an employee of the Company, effective April 1, 2025
  evidence_url: https://www.sec.gov/Archives/edgar/data/1658247/000095017025051179/0000950170-25-051179-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.